IDH1 and glioblastoma: The results demonstrated that patients older than 65 years had more high-risk proportions, patients with wild-type IDH1 GBM had more high-risk proportions, and patients with GBM of the mesenchymal subtype had the highest high-risk proportions (Bonferroni's correction).